王磊
师资介绍
王磊,男,汉族,1989年3月生,博士,讲师。入选江苏省2022年“双创博士”项目。
教育经历:
2008.09-2012.06山东大学,制药工程,学士
2012.09-2015.06山东大学,药物化学,硕士
2015.10-2019.03日本九州大学,制药科学,博士(国家公派留学)
工作经历:
2019.04-2020.03日本京都大学,合成生物化学,博士后
2020.04-2021.07日本九州大学,核酸药物化学,博士后
2021.11-至今 南通大学,药学院,讲师
研究方向:
核酸药物化学,小分子新药创制
基金项目:
江苏省“双创博士”项目,2022-2025,在研,主持
南通大学高层次人才项目,2022-2025,在研,主持
日本笹川科学研究基金,2018-2019,结题,主持
科研成果:
近5年侧重于非天然核酸药物以及小分子创新药物的研制工作。课题组主要应用化学生物学、药物化学、药剂学、有机化学和药理学等多学科交叉策略研究非天然核酸药物和小分子药物在肿瘤疾病中的潜在靶标及其治疗作用。研究工作受到国家自然科学基金委员会、江苏省科技厅和南通市科技局各类基金项目支持,取得了一系列具有显著科学价值和创新意义的成果。在Nucleic Acids Research,Chemical Communications等期刊发表专业学术论文10余篇,授权国家发明专利5项。
代表性论文:
Wang, L.; Wang, D.; Lei, W.; Sun, T.; Gu, B.; Dong, H.; Taniguchi, Y.; Liu, Y.; Ling, Y. Trigonometric Bundling Disulfide Unit Starship Synergizes More Effectively to Promote Cellular Uptake.Int. J. Mol. Sci. 2024, 25, 7518.
Wang L, Ling Y, Tian Y, Wang X, Sasaki S, Taniguchi Y. The Development of Non-natural Type Nucleoside to Stabilize Triplex DNA Formation against CG and TA Inversion Site.Curr Med Chem. 2024, 31(19):2663-2686.
Xie X, Sun T, Pan H, Ji D, Xu Z, Gao G, Miao J,Wang L, Zhang Y, Liu J, Ling Y, Su X. Development of Novel β-Carboline/Furylmalononitrile Hybrids as Type I/II Photosensitizers with Chemo-Photodynamic Therapy and Minimal Toxicity.Mol Pharm. 2024, 21(7):3553-3565.
Wang L, Notomi R, Sasaki S, Taniguchi Y. Inhibition of transcription and antiproliferative effects in a cancer cell line using antigene oligonucleotides containing artificial nucleoside analogues.RSC Med Chem. 2023, 26;14(8):1482-1491.
Lei Wang, Hiroshi Nonaka, Itaru Hamachi, Chapter 8 - Recent progress of subcellular-compartment-focused chemical proteomics In Developments in Organic Chemistry, Advances in Chemical Proteomics, Elsevier, 2022, Pages 217-247.
Notomi R,Wang L, Sasaki S, Taniguchi Y. Design and synthesis of purine nucleoside analogues for the formation of stable anti-parallel-type triplex DNA with duplex DNA bearing the 5mCG base pair.RSC Adv. 2021, 16;11(35):21390-21396.
Wang L, Okamura H , Sasaki S , Taniguchi Y . Enhancements in the utilization of antigene oligonucleotides in the nucleus by booster oligonucleotides.Chem Commun. 2020 Aug 28;56(67):9731-9734.
Wang L, Taniguchi Y, Okamura H, Sasaki S. Modification of the aminopyridine unit of 2'-deoxyaminopyridinyl-pseudocytidine allowing triplex formation at CG interruptions in homopurine sequences.Nucleic Acids Res. 2018 Sep 28;46(17):8679-8688.
Wang L, Taniguchi Y, Okamura H, Sasaki S. Effect of the 3-halo substitution of the 2'-deoxy aminopyridinyl-pseudocytidine derivatives on the selectivity and stability of antiparallel triplex DNA with a CG inversion site.Bioorg Med Chem. 2017, 15;25(14):3853-3860.